Investigating the potential of histotripsy to reprogram the tumor microenvironment by altering tumor vasculature

---

Presentation Time: 02:00 PM–02:15 PM
Abstract ID: 4700 - B

Presenting Author:
Heineken Queen Daguplo, Univ. of Michigan Med. Sch.

Co-Authors:
Brian Song, Univ. of Michigan; Natalie Gatteno, Univ. of Michigan; Chaitanya Karanam, Univ. of Michigan; Katherine Buglak, Univ. of Michigan; Hanna Kim, Univ. of Michigan; Zhen Xu, Univ. of Michigan; Michal A Olszewski, Univ. of Michigan; Clifford S Cho, Univ. of Michigan; Anutosh Ganguly, Univ. of Michigan;

View Abstract Details

LAG3 and PD1 synergize on CD8⁺ T cells to drive T cell exhaustion and hinder autocrine IFNγ-dependent anti-tumor immunity

---

Presentation Time: 02:15 PM–02:30 PM
Abstract ID: 4179 - B

Presenting Author:
Samuel C Butler, Univ. of Pittsburgh Sch. of Med.

Co-Authors:
Lawrence P Andrews, Univ. of Pittsburgh Sch. of Med.; Jian Cui, Univ. of Pittsburgh Sch. of Med.; Anthony R Cillo, Univ. of Pittsburgh Sch. of Med.; Carly Cardello; Chang Liu, Univ. of Pittsburgh Sch. of Med.; Erin A Brunazzi, Univ. of Pittsburgh Sch. of Med.; Andrew Baessler, Univ. of Pittsburgh Sch. of Med.; Bingxian Xie, Univ. of Pittsburgh Sch. of Med.; Sheryl R Kunning, Univ. of Pittsburgh Med. Ctr.; Shin Foong Ngiow, Univ. of Pennsylvania Perelman Sch. of Med.; Yinghui Jane Huang, Univ. of Pennsylvania Perelman Sch. of Med.; Sasikanth Manne, Univ. of Pennsylvania Perelman Sch. of Med.; Arlene H Sharpe, Harvard Med. Sch.; Greg M Delgoffe, Univ. of Pittsburgh Sch. of Med.; E. John Wherry, Univ. of Pennsylvania Perelman Sch. of Med.; John M Kirkwood, Univ. of Pittsburgh Sch. of Med.; Tulia C Bruno, Univ. of Pittsburgh Med. Ctr.; Creg J Workman, Univ. of Pittsburgh Sch. of Med.; Dario A.A. Vignali, Univ. of Pittsburgh Sch. of Med.;

View Abstract Details

Siglec-7/9 are glyco-immune checkpoints for enhanced immunotherapy in prostate cancer

---

Presentation Time: 02:30 PM–02:45 PM
Abstract ID: 5187 - B

Presenting Author:
Ru Wen, Stanford Univ. Sch. of Med.

Co-Authors:
G Edward Marti, Stanford Univ. Sch. of Med.; Jessica Stark, Stanford Univ. Sch. of Med.; Fernando Jose Garcia Marques, Stanford Univ. Sch. of Med.; Abel Bermudez, Stanford Univ. Sch. of Med.; Nick Riley, Stanford Univ. Sch. of Med.; Xiangyue Zhang, Stanford Univ. Sch. of Med.; Hongjuan Zhao, Stanford Univ. Sch. of Med.; Edgar Engleman, Stanford Univ. Sch. of Med.; Carolyn Bertozzi, Stanford Univ. Sch. of Med.; Sharon Pitteri, Stanford Univ. Sch. of Med.; James Brooks, Stanford Univ. Sch. of Med.;

View Abstract Details

Roles for the chemokine receptor CCR6 in pancreatitis and pancreas cancer

---

Presentation Time: 02:45 PM–03:00 PM
Abstract ID: 5421 - B

Presenting Author:
Donovan Drouillard, Med. Col. of Wisconsin

Co-Authors:
Brian Volkman, Med. Col. of Wisconsin; Michael Dwinell, Med. Col. of Wisconsin;

View Abstract Details

IL-9 immunotherapy for lung tumor growth

---

Presentation Time: 03:00 PM–03:15 PM
Abstract ID: 5750 - B

Presenting Author:
Jilu Zhang, Indiana Univ. Sch. of Med., Indiana Univ. Simon Comp. Cancer Ctr.

Co-Authors:
Anthony Cannon, Indiana Univ. Sch. of Med.; Huaxin Zhou, Indiana Univ. Sch. of Med.; Catherine R Sears, Indiana Univ. Sch. of Med.; Mark H Kaplan, Indiana Univ. Sch. of Med.;

View Abstract Details

Inducible Costimulatory Molecule (ICOS) signaling supports Th17 therapy efficacy

---

Presentation Time: 03:15 PM–03:30 PM
Abstract ID: 4101 - B

Presenting Author:
Megen C Wittling, Winship Cancer Inst., Emory Univ.

Co-Authors:
Hannah Knochelmann, Stanford Med.; Anna C Cole, Emory Univ.; Megan M Wyatt, Winship Cancer Inst., Emory Univ.; Ayana T Ruffin, Winship Cancer Inst., Emory Univ.; Soundharya Kumarasan, Emory Univ.; Frances J Bennett, Emory Univ.; Shannon Swisher, Emory Univ.; Chrystal M Paulos, Emory Univ.; Gregory B Lesinski, Emory Univ.;

View Abstract Details